Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Form S-8 NOMURA HOLDINGS INC
-
Las Vegas Sands (LVS) PT Raised to $57 at Nomura/Instinet
-
F5 Networks (FFIV) PT Lowered to $110 at Nomura/Instinet
-
Texas Instruments (TXN) PT Raised to $90 at Nomura/Instinet
-
Chipotle Mexican Grill (CMG) PT Lowered to $291 at Nomura/Instinet
-
Nomura/Instinet Starts Marriott Vacations Worldwide (VAC) at Buy
-
Nomura/Instinet Starts PQ Group (PQG) at Buy
-
Najib will aim to win over voters in last budget before elections
-
Form 6-K NOMURA HOLDINGS INC For: Oct 23
-
Turkey banking shares weaker, regulator dismisses Iran sanctions report
-
Nomura/Instinet Starts Deciphera (DCPH) at Buy
-
Noble Group to sell oil liquids unit to Vitol, flags $1.2 billion loss
-
Apple (AAPL): Shifting 5 Million iPhone Units - Nomura/Instinet
-
PayPal (PYPL) PT Raised to $79 at Nomura/Instinet
-
In Kuroda's face - researchers find ways to predict central bank changes
-
Program on International Financial Systems (PIFS) at Harvard Law School Hosts 20th Anniversary Japan Gala, Announces Organizational Changes
-
Nomura/Instinet Downgrades LG Display (LPL) to Neutral, 'Multiple Headwinds Overshadow Long-term OLED Prospects\
-
Surging wages lead to monetary tightening in Central Europe
-
KMG Chemicals (KMG) Prices 3M Share Upsized Common Offering at $54/Sh
-
Chipotle Mexican Grill (CMG) PT Lowered to $338 at Nomura/Instinet, Cuts EPS Estimates
-
KMG Announces Upsizing and Pricing of Common Stock Offering
-
Qudian (QD) IPO Opens 43% Higher
-
Qudian Inc. (QD) Prices 37.5M ADS IPO at $24/Sh
-
Qudian Inc. Announces Pricing of Initial Public Offering
-
Japan Inc wants Abe election win, but smaller majority
-
dotCMS Introduces Layout-as-a-Service Along With Significant Push Publishing and Auto Scaling Improvements in Latest Release
-
ATLANTIC-ACM Delivers 2017 Metro Wholesale Service Provider Excellence Awards
-
dotCMS Introduces Layout-as-a-Service Along With Significant Push Publishing and Auto Scaling Improvements in Latest Release
-
Aramark Services (ARMK): Raising PT To $47 - Nomura/Instinet
-
McDonald's (MCD) PT Raised to $183 at Nomura/Instinet, 'Survey Indicates MCD More than Holding Its Own'
-
Singapore September exports post surprise decline as electronics stumble
-
KMG Chemicals (KMG) Announces 2.6M Share Common Offering
-
KMG Announces Common Stock Offering
-
Micron Technology (MU) PT Raised to $50 at Nomura/Instinet; Offering Concerns are 'Overblown'
-
F5 Networks (FFIV) PT Raised to $120 at Nomura/Instinet
-
PayPal (PYPL) PT Raised to $75 at Nomura/Instinet
-
Bank of America (BAC) PT Raised to $30 at Nomura/Instinet
-
Exelixis (EXEL) Granted U.S. FDA Priority Review for CABOMETYX as Treatment for Previously Untreated Advanced Renal Cell Carcinom
-
Exelixis Announces U.S. FDA Grants Priority Review for CABOMETYX® (Cabozantinib) as a Treatment for Previously Untreated Advanced Renal Cell Carcinoma
-
Tesla (TSLA): Thoughts From Expert Call With China Automotive Strategist - Nomura/Instinet
-
China banking regulator, Hubei chief front runners to head central bank: sources
-
UPDATE: Macau Trends Are Fine - Nomura
-
Drew Forman and Evan Karp Join Cowen’s Derivatives Sales and Trading Team
-
Form 6-K NOMURA HOLDINGS INC For: Oct 12
-
Protagonist Therapeutics (PTGX) Prices 3.53M Share Common Offering at $17/Sh
-
Nomura/Instinet Downgrades Juniper Networks (JNPR) to Neutral
-
Protagonist Therapeutics Prices Public Offering of Common Stock
-
Orchid Island Capital Announces October 2017 Monthly Dividend and September 30, 2017 RMBS Portfolio Characteristics
-
Protagonist Therapeutics (PTGX) Announces Proposed Common Share Offering
-
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock

